Details for New Drug Application (NDA): 212330
The generic ingredient in EMPAGLIFLOZIN is empagliflozin; metformin hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the empagliflozin; metformin hydrochloride profile page.
Summary for 212330
| Tradename: | EMPAGLIFLOZIN |
| Applicant: | Invagen Pharms |
| Ingredient: | empagliflozin |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Sep 22, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Sep 22, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
